Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease.
暂无分享,去创建一个
Yanyuan Ma | Karen Marder | Tianle Chen | Yuanjia Wang | Yanyuan Ma | K. Marder | D. Langbehn | Yuanjia Wang | Douglas R Langbehn | Tianle Chen
[1] A. MacDonald,et al. Huntington's disease, critical illness insurance and life insurance , 2004 .
[2] M. Hayden,et al. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. , 1995, American journal of human genetics.
[3] Jane S. Paulsen,et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.
[4] C. McMurray. Mechanisms of trinucleotide repeat instability during human development , 2010, Nature Reviews Genetics.
[5] C A Ross,et al. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases , 1995, Neuron.
[6] C. Ross,et al. Huntington's disease: from molecular pathogenesis to clinical treatment , 2011, The Lancet Neurology.
[7] D. Falush,et al. Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. , 2001, American journal of human genetics.
[8] C A Ross,et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.
[9] E. Ray Dorsey,et al. Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study , 2012, PloS one.
[10] T. Foroud,et al. Differences in duration of Huntington’s disease based on age at onset , 1999, Journal of neurology, neurosurgery, and psychiatry.
[11] Hongyu Zhao,et al. Practical Issues in Building Risk-Predicting Models for Complex Diseases , 2010, Journal of biopharmaceutical statistics.
[12] P S Harper,et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. , 1996, American journal of human genetics.
[13] E D Louis,et al. Accuracy of family history data on Parkinson’s disease , 2003, Neurology.
[14] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[15] M. Hayden,et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. , 1997, American journal of human genetics.
[16] T. Louis. Finding the Observed Information Matrix When Using the EM Algorithm , 1982 .
[17] Jane S. Paulsen,et al. CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] Karen Marder,et al. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. , 2008, Archives of neurology.
[19] E Ray Dorsey,et al. Communicating clinical trial results to research participants. , 2008, Archives of neurology.
[20] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.